Drugs / 500 mg [14C]-LX1606
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01932528 | Aug → Sep 2013 | carcinoid syndrome | Lexicon Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 500 mg [14C]-LX1606 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01932528 ↗ |